S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
BREAKING: Tiny biotech successfully treats blindness (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
BREAKING: Tiny biotech successfully treats blindness (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Stop Trading Like A Turtle (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
BREAKING: Tiny biotech successfully treats blindness (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
BREAKING: Tiny biotech successfully treats blindness (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Stop Trading Like A Turtle (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
BREAKING: Tiny biotech successfully treats blindness (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
BREAKING: Tiny biotech successfully treats blindness (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Stop Trading Like A Turtle (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums
S&P 500   4,282.37
DOW   33,762.76
QQQ   354.65
MarketBeat Week in Review – 5/29 - 6/2
BREAKING: Tiny biotech successfully treats blindness (Ad)
Biden signs debt ceiling bill that pulls US back from brink of unprecedented default
Russia bans 'unfriendly' countries' journalists from showpiece economic gathering
BREAKING: Tiny biotech successfully treats blindness (Ad)
Slow start to New York's legal pot market leaves farmers holding the bag
Oil tanker breaks down in Egypt's Suez Canal, briefly disrupting traffic in the global waterway
Stop Trading Like A Turtle (Ad)
With oil prices slumping, OPEC+ producers weigh more production cuts
Las Vegas ballpark pitch revives debate over public funding for sports stadiums

Evolent Health (EVH) Stock Forecast, Price & News

$31.03
+1.20 (+4.02%)
(As of 06/2/2023 ET)
Compare
Today's Range
$30.10
$31.06
50-Day Range
$28.47
$36.44
52-Week Range
$21.83
$39.78
Volume
1.13 million shs
Average Volume
991,407 shs
Market Capitalization
$3.50 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$47.00

Evolent Health MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.90 Rating Score
Upside/​Downside
51.5% Upside
$47.00 Price Target
Short Interest
Bearish
5.14% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.93mentions of Evolent Health in the last 14 days
Based on 4 Articles This Week
Insider Trading
Selling Shares
$13.15 M Sold Last Quarter
Proj. Earnings Growth
242.11%
From $0.19 to $0.65 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.26 out of 5 stars

Computer And Technology Sector

265th out of 609 stocks

Management Services Industry

3rd out of 6 stocks


EVH stock logo

About Evolent Health (NYSE:EVH) Stock

Evolent Health, Inc. engages in the provision of healthcare delivery and payment services. It deals with population health management, health plan and third party administration, network performance and pharmacy benefit management, risk adjustment, analytics and performance improvement, and technology and electronic medical record integration. The firm operates through Services and True Health segments. The Services segment includes clinical and administrative solutions such as total cost of care management and specialty care management and comprehensive health plan administrative services. The True Health segment offers a physician-led health plan for employer-sponsored health coverage. The company was founded by Frank J. Williams, Seth B. Blackley, and Thomas Peterson III in August 2011 and is headquartered in Arlington, VA.

Receive EVH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter.

EVH Stock News Headlines

66,000% upside on tiny biotech?
The Wall Street Journal reports that this medical breakthrough is "Transforming Medicine." One analyst calculated that it could be worth $1 Trillion, making the upside potential of this small-cap 66,000% above today's price.
StockNews.com Begins Coverage on Evolent Health (NYSE:EVH)
Evolent Health (EVH) Gets a Buy from RBC Capital
“Amazon Loophole” could hand you $28,544 in “royalty” payouts
Thanks to a little-known IRS loophole… Regular Americans can collect up to $28,544 (or more) in payouts from what Brad Thomas calls the “Amazon secret royalty program…” See how to collect the next payout before the strict cutoff deadline.
Evolent Health (EVH) Beats Q1 Earnings Estimates
Recap: Evolent Health Q1 Earnings
Evolent Health (NYSE:EVH) Now Covered by Stephens
See More Headlines

EVH Price History

EVH Company Calendar

Last Earnings
5/03/2023
Today
6/03/2023
Next Earnings (Estimated)
8/01/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Management services
Sub-Industry
N/A
Employees
5,100
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$47.00
High Stock Price Forecast
$59.00
Low Stock Price Forecast
$32.00
Forecasted Upside/Downside
+51.5%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.90
Research Coverage
10 Analysts

Profitability

Net Income
$-19,160,000.00
Pretax Margin
-9.85%

Debt

Sales & Book Value

Annual Sales
$1.35 billion
Cash Flow
$1.54 per share
Book Value
$9.96 per share

Miscellaneous

Free Float
107,936,000
Market Cap
$3.50 billion
Optionable
Optionable
Beta
1.54

Key Executives

  • Seth B. BlackleySeth B. Blackley
    Chief Executive Officer & Non-Independent Director
  • Dan McCarthy
    President
  • Steven TutewohlSteven Tutewohl
    Chief Operating Officer
  • John Johnson
    Chief Financial Officer
  • John Tam
    Chief Strategy Officer













EVH Stock - Frequently Asked Questions

Should I buy or sell Evolent Health stock right now?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Evolent Health in the last twelve months. There are currently 1 hold rating and 9 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" EVH shares.
View EVH analyst ratings
or view top-rated stocks.

What is Evolent Health's stock price forecast for 2023?

10 Wall Street research analysts have issued 1 year price targets for Evolent Health's stock. Their EVH share price forecasts range from $32.00 to $59.00. On average, they predict the company's stock price to reach $47.00 in the next twelve months. This suggests a possible upside of 51.5% from the stock's current price.
View analysts price targets for EVH
or view top-rated stocks among Wall Street analysts.

How have EVH shares performed in 2023?

Evolent Health's stock was trading at $28.08 on January 1st, 2023. Since then, EVH stock has increased by 10.5% and is now trading at $31.03.
View the best growth stocks for 2023 here
.

Are investors shorting Evolent Health?

Evolent Health saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 5,790,000 shares, an increase of 9.7% from the April 30th total of 5,280,000 shares. Based on an average trading volume of 974,900 shares, the short-interest ratio is currently 5.9 days.
View Evolent Health's Short Interest
.

When is Evolent Health's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 1st 2023.
View our EVH earnings forecast
.

How were Evolent Health's earnings last quarter?

Evolent Health, Inc. (NYSE:EVH) posted its earnings results on Wednesday, May, 3rd. The technology company reported $0.11 EPS for the quarter, beating the consensus estimate of $0.04 by $0.07. The technology company had revenue of $427.69 million for the quarter, compared to analyst estimates of $435.58 million. Evolent Health had a negative net margin of 2.28% and a positive trailing twelve-month return on equity of 7.86%.

What guidance has Evolent Health issued on next quarter's earnings?

Evolent Health issued an update on its second quarter 2023 earnings guidance on Wednesday, May, 3rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $455.00 million-$470.00 million, compared to the consensus revenue estimate of $464.93 million.

What is Seth Blackley's approval rating as Evolent Health's CEO?

12 employees have rated Evolent Health Chief Executive Officer Seth Blackley on Glassdoor.com. Seth Blackley has an approval rating of 100% among the company's employees. This puts Seth Blackley in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Evolent Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Evolent Health investors own include CA (CA), BlackRock (BLK), Universal Insurance (UVE), Endologix (ELGX), Advanced Micro Devices (AMD), Energy Transfer (ET), Chipotle Mexican Grill (CMG), Ford Motor (F), Cisco Systems (CSCO) and Heron Therapeutics (HRTX).

When did Evolent Health IPO?

(EVH) raised $150 million in an initial public offering on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers.

What is Evolent Health's stock symbol?

Evolent Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EVH."

Who are Evolent Health's major shareholders?

Evolent Health's stock is owned by many different retail and institutional investors. Top institutional investors include FMR LLC (13.18%), BlackRock Inc. (6.24%), Granahan Investment Management LLC (3.00%), Wellington Management Group LLP (2.25%), Dimensional Fund Advisors LP (2.24%) and State Street Corp (1.67%). Insiders that own company stock include Cheryl Scott, Frank J Williams, Frank J Williams, John Paul Johnson, Jonathan Weinberg, Mary Bridget Duffy, Seth Blackley, Simon Maisey and Steve Tutewohl.
View institutional ownership trends
.

How do I buy shares of Evolent Health?

Shares of EVH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Evolent Health's stock price today?

One share of EVH stock can currently be purchased for approximately $31.03.

How much money does Evolent Health make?

Evolent Health (NYSE:EVH) has a market capitalization of $3.50 billion and generates $1.35 billion in revenue each year. The technology company earns $-19,160,000.00 in net income (profit) each year or ($0.38) on an earnings per share basis.

How many employees does Evolent Health have?

The company employs 5,100 workers across the globe.

How can I contact Evolent Health?

Evolent Health's mailing address is 800 NORTH GLEBE RD SUITE 500, ARLINGTON VA, 22203. The official website for the company is www.evolenthealth.com. The technology company can be reached via phone at (571) 389-6000, via email at investorrelations@evolenthealth.com, or via fax at 571-389-6001.

This page (NYSE:EVH) was last updated on 6/4/2023 by MarketBeat.com Staff

My Account -